🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of a Peer Support Media Model on Obesity and Sarcopenia Awareness in At-Risk College Students

RecruitingNAAges 18 Years - 25 YearsAllChina Medical University Hospital
NCT06964880 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Sarcopenic obesity refers to a condition characterized by high body fat percentage and insufficient muscle mass, posing significant risks to physical and mental health. This issue is not limited to the elderly; it is increasingly common among younger populations as well. According to the National Nutrition and Health Survey conducted between 2017 and 2020, high rates of eating out due to study and work lifestyles in Taiwan result in limited access to nutritious food. The Ministry of Health and Welfare's statistics from 2021 show that only 33.9% of the population engages in regular exercise. Sarcopenic obesity is associated with physical activity and nutritional intake. The European Working Group on Sarcopenia in Older People has urged the public to maintain a balanced diet and establish exercise habits early to reduce the risk of sarcopenic obesity. Younger individuals are more likely to

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Undergraduate students in years 1 to 4 at a medical university in central Taiwan * Body Mass Index (BMI) between 23 and 27 or body fat percentage between 25% and 35% * Aged 18 to 25 years * No diagnosis of any chronic disease Exclusion Criteria: * University students with restricted limb movement who are unable to exercise according to instructions. * Any condition that may restrict the proper use of a dynamometer (e.g., hand pain, osteoarthritis, or rheumatoid arthritis).
💊

What it tests

  • Exercise with video on media platform
  • Printed Educational Handout
📍

Where

1 site
Ya-Ling Tzeng
Taichung, Taiwan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy